ECHA management board elects new deputy chairman
Martin Lynch takes the role
Lynch, from Ireland, will hold the role for the next two years. Dr Thomas Jakl, from Austria, is chairman.
You may also like
Ingredients
dsm-firmenich launches Biond pharmaceutical-grade vitamin portfolio for cell culture and biologics manufacturing
The range targets critical metabolic pathways supporting cell growth, viability and protein expression — available globally through Brenntag's BYPHAR distribution network ahead of its CPHI Milan debut
Manufacturing
CARBOGEN AMCIS announces successful first FDA pre-approval inspection at its Vionnaz site
CARBOGEN AMCIS part of the Dishman Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of the first U.S. Food and Drug Administration (FDA) Pre-Approval Inspection (PAI) at its Vionnaz facility in Switzerland. The inspection concluded without the issuance of a Form 483